Drug Approval | April 30, 2026
Wanbury's Patalganga site clears Korea FDA inspection with zero observations
Patalganga plant received zero observation from USFDA earlier
Patalganga plant received zero observation from USFDA earlier
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
The planned facility, to be built at Samsung’s Bio Campus II, is set to become a launchpad for up to 30 emerging biotech firms
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
Launches advanced bone density systems in India & Dubai
The collaboration will center on expanding access to Eastman’s Esmeri technology
Presbyopia, the age-related loss of near vision, could soon be treated successfully
The X CUBE 50 integrates ALPINION’s advanced X+ Architecture
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Subscribe To Our Newsletter & Stay Updated
